跳至主要内容
临床试验/NCT07521306
NCT07521306已完成不适用

The Use of Biomarkers for Predicting Mortality in Patients With Suspected Sepsis

Antalya Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
250
试验地点
1
主要终点
28-day mortality

研究概览

简要总结

This retrospective study aimes to analyze the association of a number of routinely performed biomarkers with mortality in patients admitted to ICU with suspected sepsis.

The study includes patients >18 years of age, who had been admitted to the ICU with suspected sepsis. At ICU admission, baseline levels of PCT, CRP, albumin and lactate as well as WBC, neutrophil and lymphocyte counts will recorded.

详细描述

This study aimes to investigate the association of a number of biomarkers with 28-day mortality of patients admitted to the ICU with suspected sepsis, which included C-reactive protein (CRP), procalcitonin (PCT), WBC count, neutrophil count, lymphocyte count, albumin and lactate.

Data will obtained from hospital electronic medical records. Data includes age, sex, duration of ICU stay, origin of infection (urinary, abdominal, pulmonary, soft tissue, central nervous system, catheter-related, mixed, others) and comorbidities (hypertension, diabetes mellitus, chronic obstructive pulmonary disease, chronic renal failure, heart failure, coronary artery disease, malignancies, others). Whether patients were admitted to the ICU following a scheduled surgery or emergency surgery will also recorded.

At admission, baseline levels of PCT, CRP, albumin and lactate as well as WBC, neutrophil and lymphocyte counts will recorded.

The primary outcome is 28-day mortality. For patients with multiple episodes requiring ICU admission, only the most recent episode will taken into consideration.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years of age
  • admission to the ICU with suspected sepsis

排除标准

  • ICU admission following cardiopulmonary resuscitation or cardiac surgery
  • Having a positive test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
  • Interruption of the treatment process because of transfer to another healthcare facility

结局指标

主要结局

28-day mortality

时间窗: 28 days

mortality within 28 days after intensive care admission

次要结局

未报告次要终点

研究者

发起方
Antalya Training and Research Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Biomarkers for Predicting Mortality in Patients With... | 临床试验